Governance Classic Home
Advanced Enzyme Technologies LimitedBiotechnologyINE837H01020
Valuation
Market Cap₹3.22K Cr
TTM PE40.20x
Forward PE36.10x
PEG3.11
Book Value₹191.87
P/B1.50x
TTM EPS₹7.16
Fwd EPS₹7.97
TTM Revenue₹444.26 Cr
TTM PAT₹80.20 Cr
TTM EBITDA₹226.79 Cr
TTM EBIT₹186.32 Cr
Last Qtr PAT₹22.30 Cr
Last Qtr EBITDA₹50.97 Cr
Last Qtr EBIT₹41.09 Cr
Profitability
ROE—
ROCE—
TTM NPM18.05%
TTM EBITDA %51.05%
Curr OPM18.92%
Last OPM18.34%
Curr NPM—
Last NPM—
Curr EPS₹2.00
Last EPS₹1.99
Balance sheet
Equity—
Reserve—
Total Debt₹0.00 Cr
D/E—
Interest %0.18%
Curr Interest₹0.04 Cr
Price / range
Close₹287.80
vs 52W High-27.28%
vs 52W Low+2.04%
MA50—
MA200—
Returns
1D-0.10%
1W-1.91%
1M-5.02%
3M-22.92%
6M—
1Y—
2Y—
3Y—
5Y—
Diwali+98.00%
Sector peers — Biotechnology
CompanyCloseMkt CapTTM P/EROE
ANTHEM928.50₹52.31K Cr83.5020.52%
ADVENZYMES287.80₹3.22K Cr40.20—
GENESIS36.45₹164.94 Cr-72.90—
VIVOBIOT16.71₹37.08 Cr-10.78—
SHREEGANES0.48₹19.13 Cr——
GVBL28.73₹8.78 Cr478.83—

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Standalone

0 lines · 0 periods

No financial result data.

Yearly results

Last 6 financial years · YoY % vs previous FY

Yearly

17 lines · 6 years
MetricFY 25-26FY 24-25FY 23-24FY 22-23FY 21-22FY 20-21
Revenue452.77+28.8%351.41-3.8%365.47+17.3%311.53+14.2%272.80-3.8%283.47
Other Income63.3961.4958.819.819.086.82
Total Income516.15+25.0%412.90-2.7%424.28+32.0%321.34+14.0%281.88-2.9%290.30
Expenditure-354.62-21.3%-292.37-7.8%-271.34-9.8%-247.06-17.8%-209.81-9.4%-191.87
Interest-0.21-0.24-0.16-0.14-0.10-0.08
PBDT000000
EBITDA110.44+56.2%70.69-32.8%105.19+40.5%74.89+3.1%72.65-27.8%100.61
Depreciation-12.08-11.41-10.90-10.28-9.56-8.93
EBIT98.36+65.9%59.28-37.1%94.29+45.9%64.61+2.4%63.09-31.2%91.68
PBT157.67+30.8%120.53-10.0%133.99+80.4%74.28+3.1%72.07-26.8%98.43
Tax-25.87-18.11-25.87-18.75-17.56-27.42
Equity22.3922.380000
OPM (%)30.5529.1932.0023.0026.0034.00
Net Profit131.81+28.7%102.42-5.3%108.12+94.7%55.53+1.9%54.51-23.2%71.01
NPM (%)25.5424.8025.0017.0019.0024.00
EPS (Rs)11.78+28.6%9.16-5.3%9.67+94.6%4.97+1.8%4.88-23.3%6.36
CEPS11.769.159.664.974.876.35

Consolidated

0 lines · 0 periods

No financial result data.

Yearly results

Last 6 financial years · YoY % vs previous FY

Yearly

17 lines · 6 years
MetricFY 25-26FY 24-25FY 23-24FY 22-23FY 21-22FY 20-21
Revenue745.76+17.1%636.91+2.1%623.87+15.4%540.64+2.1%529.38+5.5%501.84
Other Income34.8333.0436.6625.466.428.85
Total Income780.59+16.5%669.95+1.4%660.53+16.7%566.09+5.7%535.80+4.9%510.69
Expenditure-559.41-15.9%-482.59-5.5%-457.58-8.5%-421.64-15.6%-364.75-21.5%-300.32
Interest-2.63-3.56-2.93-2.42-1.80-1.59
PBDT000000
EBITDA229.07+17.8%194.44-4.9%204.46+30.7%156.45-22.3%201.41-13.0%231.52
Depreciation-40.09-36.56-35.24-35.03-34.98-28.41
EBIT188.98+19.7%157.88-6.7%169.22+39.4%121.42-27.0%166.43-18.1%203.11
PBT232.54+24.1%187.36-0.2%187.82+33.8%140.39-17.9%171.06-18.7%210.37
Tax-58.93-53.39-50.87-36.52-47.26-58.91
Equity22.3922.380000
OPM (%)29.7927.9728.4324.8031.9341.19
Net Profit173.61+29.6%133.97-2.2%136.95+31.8%103.87-16.1%123.80-18.3%151.46
NPM (%)22.2420.0020.7318.3523.1129.66
EPS (Rs)15.08+28.7%11.72-1.7%11.92+26.1%9.45-11.7%10.70-18.3%13.09
CEPS15.0611.7111.929.4510.6813.07

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

13
YearTypeAmountEx-Date
2026Final Dividend1.3524 Jul 2026
2025Final Dividend1.223 Jul 2025
2026Interim Dividend416 May 2025
2024Final Dividend1.118 Jul 2024
2025Interim Dividend417 May 2024
2023Final Dividend104 Aug 2023
2024Interim Dividend419 May 2023
2022Final Dividend111 Aug 2022
2021Final Dividend0.931 Aug 2021
2020Final Dividend0.609 Jul 2020
2019Final Dividend0.601 Aug 2019
2018Final Dividend0.506 Sep 2018
2017Final Dividend0.404 Sep 2017

Bonus

0

No bonus history.

Split

1
YearRatioEx-Date
2017Rs.10/- to Rs.2/-25 May 2017
Loading company dashboard...
Fetching ratios, charts, and peers